Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
You can purchase shares of Windtree Therapeutics (NASDAQ:WINT) through any online brokerage.
Other companies in Windtree Therapeutics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Bone Biologics (NASDAQ:BBLG) and Qualigen Therapeutics (NASDAQ:QLGN).
Windtree Therapeutics has a consensus price target of $1.00.
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.4581 last updated November 18, 2024 at 7:41 AM EST.
There are no upcoming dividends for Windtree Therapeutics.
Windtree Therapeutics’s Q3 earnings are confirmed for Friday, November 29, 2024.
There is no upcoming split for Windtree Therapeutics.
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.